ContractCommercialization Agreement • February 6th, 2018 • Taiwan Liposome Company, Ltd. • Pharmaceutical preparations
Contract Type FiledFebruary 6th, 2018 Company Industry*** = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
ContractShareholders’ Agreement • February 6th, 2018 • Taiwan Liposome Company, Ltd. • Pharmaceutical preparations
Contract Type FiledFebruary 6th, 2018 Company Industry*** = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.